Form4insider filings, from the source

SEC Form 4 · accession 0001144204-17-052056

CASI Pharmaceuticals, Inc. · CASI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Wei-Wu He
Director
Period of report
Oct 10, 2017
Accepted (ET)
Oct 11, 2017 · 4:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000895051

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Oct 10, 2017P100,000$1.95A847,527D
Common StockF2holding———1,871,605ISee Footnote
Common StockF3holding———441,072ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses